Galactosylsphingamides: New α-GalCer Analogues to Probe the F'-pocket of CD1d

Overview

Journal Sci Rep

Specialty Science

Date 2017 Jun 29

PMID 28655912

Citations 6

Authors

Joren Guillaume

Jing Wang

Jonas Janssens

Soumya G Remesh

Martijn D P Risseeuw

Tine Decruy

Mathy Froeyen

Dirk Elewaut

Dirk M Zajonc

Serge Van Calenbergh

Affiliations

Soon will be listed here.

Abstract

Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulation, as upon CD1d-mediated stimulation with KRN7000, a synthetic α-galactosylceramide, they produce a vast amount of cytokines. Here we present a synthesis that allows swift modification of the phytosphingosine side chain by amidation of an advanced methyl ester precursor. The resulting KRN7000 derivatives, termed α-galactosylsphingamides, were evaluated for their capacity to stimulate iNKT-cells. While introduction of the amide-motif in the phytosphingosine chain is tolerated for CD1d binding and TCR recognition, the studied α-galactosylsphingamides showed compromised antigenic properties.

Citing Articles

State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues.

Praveena T, Le Nours J Front Immunol. 2024; 15:1479382.

PMID: 39669569 PMC: 11635198. DOI: 10.3389/fimmu.2024.1479382.

An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo.

Tsuji M, Nair M, Masuda K, Castagna C, Chong Z, Darling T Nat Commun. 2023; 14(1):3959.

PMID: 37402814 PMC: 10319732. DOI: 10.1038/s41467-023-39738-1.

The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3.

Cameron G, Cheng J, Godfrey D, Timmer M, Stocker B, Dangerfield E RSC Adv. 2022; 12(29):18493-18500.

PMID: 35799937 PMC: 9215340. DOI: 10.1039/d2ra02373c.

A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.

Wang J, Guillaume J, Janssens J, Remesh S, Ying G, Bitra A J Biol Chem. 2019; 294(39):14345-14356.

PMID: 31391251 PMC: 6768634. DOI: 10.1074/jbc.RA119.009963.

Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.

Ying G, Wang J, Mallevaey T, Van Calenbergh S, Zajonc D J Biol Chem. 2019; 294(35):12947-12956.

PMID: 31296659 PMC: 6721955. DOI: 10.1074/jbc.RA119.009403.

References

Smyth M, Crowe N, Hayakawa Y, Takeda K, Yagita H, Godfrey D . NKT cells - conductors of tumor immunity?. Curr Opin Immunol. 2002; 14(2):165-71. DOI: 10.1016/s0952-7915(02)00316-3. View

Schiefner A, Fujio M, Wu D, Wong C, Wilson I . Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands. J Mol Biol. 2009; 394(1):71-82. PMC: 2792987. DOI: 10.1016/j.jmb.2009.08.061. View

Berkers C, Ovaa H . Immunotherapeutic potential for ceramide-based activators of iNKT cells. Trends Pharmacol Sci. 2005; 26(5):252-7. DOI: 10.1016/j.tips.2005.03.005. View

Wu D, Zajonc D, Fujio M, Sullivan B, Kinjo Y, Kronenberg M . Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A. 2006; 103(11):3972-7. PMC: 1449630. DOI: 10.1073/pnas.0600285103. View

Giaccone G, Punt C, Ando Y, Ruijter R, Nishi N, Peters M . A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res. 2002; 8(12):3702-9. View

Kim Y, Kim J, Oh K, Lee D, Park S . Heteroaromatic Moieties in the Sphingosine Backbone of α-Galactosylceramides for Noncovalent Interactions with CD1d. ACS Med Chem Lett. 2014; 3(2):151-4. PMC: 4025800. DOI: 10.1021/ml200278u. View

Zhou X, Forestier C, Goff R, Li C, Teyton L, Bendelac A . Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides. Org Lett. 2002; 4(8):1267-70. DOI: 10.1021/ol025565+. View

McCarthy C, Shepherd D, Fleire S, Stronge V, Koch M, Illarionov P . The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med. 2007; 204(5):1131-44. PMC: 2118584. DOI: 10.1084/jem.20062342. View

Miyamoto K, Miyake S, Yamamura T . A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 2001; 413(6855):531-4. DOI: 10.1038/35097097. View

10.

Koch M, Stronge V, Shepherd D, Gadola S, Mathew B, Ritter G . The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol. 2005; 6(8):819-26. DOI: 10.1038/ni1225. View

11.

Toba T, Murata K, Futamura J, Nakanishi K, Takahashi B, Takemoto N . Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile. Bioorg Med Chem. 2012; 20(9):2850-9. DOI: 10.1016/j.bmc.2012.03.025. View

12.

Chang Y, Huang J, Tsai Y, Hung J, Wu D, Fujio M . Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A. 2007; 104(25):10299-304. PMC: 1965507. DOI: 10.1073/pnas.0703824104. View

13.

Raju R, Castillo B, Richardson S, Thakur M, Severins R, Kronenberg M . Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000. Bioorg Med Chem Lett. 2009; 19(15):4122-5. PMC: 2710405. DOI: 10.1016/j.bmcl.2009.06.005. View

14.

Trappeniers M, Van Beneden K, Decruy T, Hillaert U, Linclau B, Elewaut D . 6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice. J Am Chem Soc. 2009; 130(49):16468-9. DOI: 10.1021/ja8064182. View

15.

Morita M, Motoki K, Akimoto K, Natori T, Sakai T, Sawa E . Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem. 1995; 38(12):2176-87. DOI: 10.1021/jm00012a018. View

16.

Li X, Chen G, Garcia-Navarro R, Franck R, Tsuji M . Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells. Immunology. 2009; 127(2):216-225. PMC: 2691787. DOI: 10.1111/j.1365-2567.2008.02943.x. View

17.

Kim Y, Oh K, Song H, Lee D, Park S . Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone. J Med Chem. 2013; 56(17):7100-9. DOI: 10.1021/jm400949h. View

18.

Borg N, Wun K, Kjer-Nielsen L, Wilce M, Pellicci D, Koh R . CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature. 2007; 448(7149):44-9. DOI: 10.1038/nature05907. View

19.

Figueroa-Perez S, Schmidt R . Total synthesis of alpha-galactosyl cerebroside. Carbohydr Res. 2000; 328(2):95-102. DOI: 10.1016/s0008-6215(00)00092-6. View

20.

Li Y, Girardi E, Wang J, Yu E, Painter G, Kronenberg M . The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med. 2010; 207(11):2383-93. PMC: 2964572. DOI: 10.1084/jem.20101335. View